A lost decade

Article

Successive governments have lauded the life sciences as a pillar of the UK economy in recent years. David Cameron talked about “a jewel in the crown”. Theresa May set out her ambition to make Britain “the global go-to place for scientists, innovators and tech investors”. And Boris Johnson has already committed to ‘supercharge’ UK science following Brexit.

There is optimism around the potential for growth in the industry – driven in no small part by a uniquely exciting moment for scientific advances.

However, new IPPR analysis shows that we have had a lost decade that has left one of our strongest sectors stagnating, even before accounting for its significant vulnerability to an unmanaged, no-deal Brexit.

In this briefing we set out key tests for policymakers looking to take the requisite steps to mitigate Brexit, as part of a strategy to support and invest in our life sciences industry.

Related items

  1. Doctor with patient for consultation, medical advice or procedure at clinic

    Taken to heart: Inequalities in heart disease in Scotland

    More than 7.6 million people across the UK live with cardiovascular disease (CVD), around twice as many as live with Alzheimer’s disease and cancer combined. 
  2. A beautiful sunset in the Scottish highlands with renewable energy wind turbines far into the horizon

    Skills passports: An essential part of a fair transition

    This month, government will publish its Clean Energy Workforce Strategy. This plan covers two aims. First, filling the growing demand for skills in clean energy industries is essential to keep on track to reach the government’s clean power…
  3. The Bank of England is watched over by a statue of the Duke of Wellington seated on his horse

    Fixing the leak: How to end the £22 billion annual taxpayer losses at the Bank of England

    The Bank of England increased its interest rates over recent years, aimed at reducing inflation. But this has also had an unintended effect on the Bank of England’s massive government bond buying – ‘quantitative easing’ – programme.